Abstract
BackgroundTumor-infiltrating CD8+ T cells and neoantigens are predictors of a favorable prognosis and response to immunotherapy with checkpoint inhibitors in many types of adult cancer, but little is known about...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have